Amiko: Luz Saúde partners with Amiko Digital Health
Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko's Respiro inhaler monitoring platform for asthma and COPD management. Earlier this year, Amiko announced that the Respiro platform received the CE mark for use with Spiromax, Nexthaler, and Ellipta inhalers, and the company had [...]
Read full article »
Amiko is an England-based digital medicine platform that offers respiratory disease management solutions for healthcare professionals.
Read more